Want to join the conversation?
$JNJ Product Update: The first schizophrenia treatment to be taken just four times a year with dosing measured in seasons, not days is now available in the United States. The three-month dosing interval of INVEGA TRINZA offers a new paradigm for treating patients with schizophrenia.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.